1. Home
  2. RR vs ENGN Comparison

RR vs ENGN Comparison

Compare RR & ENGN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Richtech Robotics Inc. Class B

RR

Richtech Robotics Inc. Class B

HOLD

Current Price

$2.82

Market Cap

690.2M

Sector

N/A

ML Signal

HOLD

Logo enGene Holdings Inc.

ENGN

enGene Holdings Inc.

HOLD

Current Price

$9.70

Market Cap

605.5M

Sector

N/A

ML Signal

HOLD

Company Overview

Basic Information
Metric
RR
ENGN
Founded
2016
1999
Country
United States
Canada
Employees
N/A
N/A
Industry
Sector
Exchange
Nasdaq
Nasdaq
Market Cap
690.2M
605.5M
IPO Year
2023
N/A

Fundamental Metrics

Financial Performance
Metric
RR
ENGN
Price
$2.82
$9.70
Analyst Decision
Strong Buy
Buy
Analyst Count
1
7
Target Price
$6.00
$22.71
AVG Volume (30 Days)
44.9M
461.0K
Earning Date
02-11-2026
03-09-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
$4,935,000.00
N/A
Revenue This Year
$143.11
N/A
Revenue Next Year
$65.57
N/A
P/E Ratio
N/A
N/A
Revenue Growth
12.39
N/A
52 Week Low
$1.37
$2.65
52 Week High
$7.43
$12.25

Technical Indicators

Market Signals
Indicator
RR
ENGN
Relative Strength Index (RSI) 39.81 52.12
Support Level $2.83 $9.30
Resistance Level $3.16 $10.20
Average True Range (ATR) 0.40 0.88
MACD -0.11 -0.07
Stochastic Oscillator 4.69 40.46

Price Performance

Historical Comparison
RR
ENGN

About RR Richtech Robotics Inc. Class B

Richtech Robotics Inc is a developer of new robotic technologies focused on transforming labor-intensive services in hospitality and other sectors currently experiencing unprecedented labor shortages. The company designs, manufacture and sells robots to restaurants, hotels, senior living centers, casinos, factories, movie theaters and other businesses. Its robots perform a variety of services including restaurant running and bussing, hotel room service delivery, floor scrubbing and vacuuming, and beverage and food preparation. The company designs its robots to be friendly, customizable to client environments, and extremely reliable.

About ENGN enGene Holdings Inc.

enGene Holdings Inc is a clinical-stage biotechnology company mainstreaming genetic medicine through the delivery of therapeutics to mucosal tissues and other organs, with the goal of creating new ways to address diseases with high clinical needs, beginning with non-muscle invasive bladder cancer (NMIBC). The Company is developing non-viral gene therapies based on its novel and proprietary dually derived chitosan, or DDX, gene delivery platform, which allows localized delivery of multiple gene cargos directly to mucosal tissues and other organs.

Share on Social Networks: